To view this email as a web page, click here.

 
Methotrexate outperforms cyclosporine in atopic dermatitis study
Methotrexate offers a better treatment profile than cyclosporin for long-term control of moderate-to-severe atopic dermatitis, shows a comparison study of two first-line immunosuppressive treatments.
Learn more.
 
Systemic conditions that can affect skin
Skin can act as a window to a patient’s general health says a physician writing in the journal Medicine. Changes in the skin can signal underlying disease from lupus to gastrointestinal disease.
Learn more.
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.